[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Cambridge Cognition Holdings Plc LSE:COG London Ordinary Share GB00B8DV9647 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 152.50 150.00 155.00 152.50 151.00 152.50 23,460 12:16:25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 6.7 -0.6 -1.5 - 48

Cambridge Cognition Share Discussion Threads

Showing 551 to 572 of 575 messages
Chat Pages: 23  22  21  20  19  18  17  16  15  14  13  12  Older
DateSubjectAuthorDiscuss
25/9/2021
12:17
htTps://www.ddw-online.com/study-to-overcome-biological-heterogeneity-challenge-to-clinic-by-2022-13281-202109/ It looks like Monument Therapeutics our @36% owned spinout is not hanging around with the money they have recently raised.
40 fathoms
21/9/2021
15:40
finnCap "CAMBRIDGE COGNITION (COG): CORP Interims Interim results to 30 June 2021 were in line with the trading update issued on 3 August, which resulted in upgrades to our forecasts and target price. On the back of a 50% (£1.5m) rise in revenues to £4.5m, adjusted EBITDA increased £0.5m to £0.2m, illustrating the operational leverage of 80% gross margin software & services. Period-end cash increased 38% (+£1.2m) in the period to£ 4.2m. Cambridge Cognition is well positioned to be a long-term beneficiary of the trend of running virtual decentralised trials, catalysed by the COVID-pandemic, and evidenced by its first contract that is assessing many thousands of patients at home. We leave forecasts unchanged, and reiterate our target price of 220p, which implies a 2021E EV/sales multiple of 5.6x for its core business and c.15p per share (c.£4.7m) for the value of its interest in Monument Therapeutics."
someuwin
21/9/2021
15:15
Bought in here for the first time today.
someuwin
21/9/2021
12:41
First time I have seen them on Proactive Investors - Good move in my view htTps://www.proactiveinvestors.co.uk/companies/news/960882/cambridge-cognition-report-50-year-on-year-growth-as-interest-in-virtual-clinical-trials-grows-960882.html
40 fathoms
21/9/2021
08:54
Good results also sufficient cash to fund working capital growth.
ywdis
21/9/2021
08:49
Agreed it is not much, but you would expect a company looking at the growth they are going to achieve in the next 5 years to be significantly loss making. The fact that they are profitable at this point is amazing, 80% gross margins help. Also this was after spending 800k on R&D. They will be doing a PBT of at least 4 million in FY24 and will still be looking a growth as far as the eye can see.
40 fathoms
21/9/2021
07:47
PBT £0.1m !? Relative to a 44m MCAP ? Revenue and order book growth are fantastic 50% and 36% respectively. ... but revenue included £3.6m of exceptional income and the £15m order book is over 1 - 6 years. There is a lot priced in. We may see more profit taking.
hatfullofsky
21/9/2021
07:20
Very positive results, increased PBT, increased contracts won, increased contract backlog, increased net cash, still investing in R&D. Confident in the future growth of the business.
40 fathoms
20/9/2021
00:28
Looks like Novartis have been busy evaluating some of Cambridge Cognition's digital products. Interestingly in this paper it shows they have use NeuroVocalix as one of the digital endpoints for self-administered home-based functional assessment in pediatric Friedreich’s ataxia htTps://onlinelibrary.wiley.com/doi/10.1002/acn3.51438 Here they have used Cambridge's Cognition Kit in a study of Novel Exploratory Tools, Digital Technologies, and Central Nervous System Biomarkers to Characterise Unipolar Depression. htTps://www.frontiersin.org/articles/10.3389/fpsyt.2021.640741/full
40 fathoms
14/9/2021
12:25
Bit of a shake before results ?
hatfullofsky
07/9/2021
10:41
This daily slide is a little worrying with results around the corner....
zimbtrader
25/8/2021
12:55
Found this, hints that there is something ticking away on the healthcare side of the business. hTtps://finance.yahoo.com/news/healthy-amplified-inks-commercial-deal-130700951.html Healthy Amplified are a US distributor of CANTAB hTtps://www.healthyamplified.com/cognition-health/
40 fathoms
20/8/2021
10:02
Summer malaise presenting a buying opportunity????
mobtheplod
03/8/2021
10:37
Nice they're "profitable" on an adjusted earnings before costs basis..,
igbertsponk
03/8/2021
07:48
Lot to like in that trading update and still lots more to come.
40 fathoms
21/7/2021
07:32
We are due a trading update and by COGs standards they are a bit slow with this one. If it does not come in the next 24 or 48 hours I have a sneaking feeling it will come with news, as there would be no other reason to delay vs previous years. Either a big contract win or collaboration would be nice. M&A, either as acquirer or acquired would be less welcome. I think the chances of a takeover approach in the next 18 months are very high indeed, one thing I am certain about is that whatever the price is I will not like it.
40 fathoms
12/7/2021
16:10
good info thanks
smithie6
12/7/2021
13:07
Order intake over the period looks like this. 2019 - Total order intake GBP 4.9million of which GBP 1.3 million were substantial and required an RNS. 2020 - Total order intake GBP 12.7 million of which GBP 4.9 million were substantial and required an RNS. 2021 - Total order intake yet to be announced of which GBP 6.4 million YTD have been substantial and required an RNS. I am quietly confident that we will break GBP 20 million for the full financial year and when smoothed out for timing of larger contracts should be looking at 15% to 20% annual growth in order intake over the following 5 years. So looking for @ GBP 40 million of annual order intake by 2026. At that point I don't think it would be wildly optimistic to add on GBP 10 million of annual healthcare related revenue.
40 fathoms
12/7/2021
12:08
2020 order intake of 5.9 million was in a Covid year. reduced I assume How might 2021 compare for order intake with 2019 ( a pre Covid year) ?
smithie6
09/7/2021
15:09
good info. thanks for sharing ('if' the co. were to have an order intake of 17-20 million this year versus 6 million last year that would be a very big % increase)
smithie6
09/7/2021
14:51
Just thought it was interesting to note that in the whole of 2020 there were GBP 5.9 million of contracts signed that required RNSs and already in 2021 we have surpassed that number with GBP 6.4 million announced. Given the overall highly supportive back drop I am very confident that we will see a significant number of additional large contracts signed before the year is out. My best guess is that we will see order in take of at very least GBP 17.5 million this year and with the strong possibility that may get well over GBP 20 million if we land a big AD contract. Things are looking very good indeed.
40 fathoms
09/7/2021
08:53
Coincidentally Open Orphan today announced a contract win for clinical trials , not the same arena as COG but makes one think
ywdis
Chat Pages: 23  22  21  20  19  18  17  16  15  14  13  12  Older
ADVFN Advertorial
Your Recent History
LSE
COG
Cambridge ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210927 11:39:02